• OPEN AN ACCOUNT
Indian Indices
Sensex
78,714.12 619.48
( 0.79%)
Global Indices
Nasdaq
52,497.89 268.83
(0.51%)
Dow Jones
7,510.69 52.06
(0.70%)
Hang Seng
64,316.33 2,448.90
(3.96%)
Nikkei 225
10,879.26 -18.01
(-0.17%)
Forex
USD-INR
95.59 -0.10
(-0.11%)
EUR-INR
109.79 0.65
(0.59%)
GBP-INR
128.11 0.75
(0.59%)
JPY-INR
0.59 0.01
(1.09%)

EQUITY - MARKET SCREENER

Tridev InfraEstates Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
531568
INE723K01018
5.0347871
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
3.93
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Oxygenta Pharmaceutical reports standalone net loss of Rs 2.10 crore in the June 2026 quarter
Jul 28,2026
Net Loss of Oxygenta Pharmaceutical reported to Rs 2.10 crore in the quarter ended June 2026 as against net loss of Rs 6.11 crore during the previous quarter ended June 2025. Sales rose 144.55% to Rs 37.00 crore in the quarter ended June 2026 as against Rs 15.13 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales37.0015.13 145
OPM %1.51-45.14 -
PBDT-1.88-7.29 74
PBT-2.50-8.14 69
NP-2.10-6.11 66